Key result
Qishen Yiqi Dropping Pill significantly reduced platelet aggregation and β-thromboglobulin levels, decreased the TXB2 to 6-Keto-PGF1α ratio, and increased cAMP levels in hyperlipidemic rabbits.
Why the study?
Does Qishen Yiqi Dropping Pill reduce platelet aggregation in hyperlipidemic rabbits?
Population
Hyperlipidemic rabbit model produced by a high fat/cholesterol diet for 6 weeks
Comparison
Qishen Yiqi Dropping Pill at doses of 2.0 g/kg… vs Hyperlipidemic model group without drug treatment
Design
Preclinical
Follow-up
14 days
Authors
Loading...
Supports further preclinical study in hyperlipidemia; hypothesis-generating from animal data and should not change practice.
Does Qishen Yiqi Dropping Pill reduce platelet aggregation in hyperlipidemic rabbits?
Qishen Yiqi Dropping Pill demonstrates antiplatelet aggregation effects in hyperlipidemic rabbits, likely mediated by increased cAMP levels.
Wang et al. (2012) studied Hyperlipidemia. Qishen Yiqi Dropping Pill (QSYQ) vs. Model group was evaluated on Platelet aggregation and β-thromboglobulin (β-TG) levels. Qishen Yiqi Dropping Pill significantly reduced platelet aggregation and β-thromboglobulin levels, decreased the TXB2 to 6-Keto-PGF1α ratio, and increased cAMP levels in hyperlipidemic rabbits.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: